Preoperative chemotherapy through intra-arterial combined with intra-venous administration in treatment of advanced gastric cancer
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 1
Abstract
Perioperative chemotherapy has been an important part of the comprehensive treatment of advanced gastric cancer. Different from the conventional systemic chemotherapy, preoperative chemotherapy through intra-arterial combined with intra-venous further optimized delivery routes according to characteristics of different drugs on the basis of combination chemotherapy，which has been studied and practiced at our center for more than 20 years. In this review, we will introduce this chemotherapy from the aspects of theoretical basis, development process, treatment advantages, and clinical research. The clinical efficacy and possible treatment mechanisms will be discussed through looking back on both clinic and basic study.
Authors and Affiliations
Guoli LI, Feilong GUO
Keywords
Related Articles
- EP ID EP750840
- DOI 10.16139/j.1007-9610.2023.01.05
- Views 14
- Downloads 0
Application of 21-Gene test in adjuvant radiotherapy for early breast cancer
Breast cancer is the most common malignant tumor in women. With the development of genomics technology and medical frontier technology, the systemic treatment of breast cancer has gradually entered the era of personalize...
<![CDATA[Interpretation of surgical procedure standard of conformal sphincter-preservation operation for low rectal cancer (2023 edition)]]>
<![CDATA[In this paper we interpretated the background about Standardized surgical procedure of conformal sphincter-preservation operation (CSPO) for low rectal cancer (2023 edition), and several key issues need to be at...
Construction of a prognostic Nomogram for patients with incidental gallbladder cancer
[Objective] To construct and validate an effective prognostic nomogram for the patients with incidental gallbladder cancer(IGBC). [Methods] The clinical data of 161 patients with IGBC requiring radical surgery admitted t...
Emerging developments in immune checkpoint inhibitor therapy for gastroenteropancreatic neuroendocrine neoplasm
Immunotherapies targeting immune checkpoints have undergone rapid evolution, and have been preliminary explored in treatment of gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) in recent years. However, their pot...
Conversion therapy of hepatocellular carcinoma: some pivotal issues to be resolved
Progress in the systemic therapies, represented by the molecular target therapies and immune checkpoint inhibitors (ICIs), have significantly improved the prognosis of unresectable hepatocellular carcinoma (uHCC), but lo...